bosentan anhydrous has been researched along with Eosinophilia, Tropical in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allanore, Y; Isvy, A; Kahan, A; Maury, E; Moachon, L | 1 |
Hasegawa, A; Ishikawa, O; Nagai, Y; Nakano, A; Nishimura, S; Yamanaka, M | 1 |
Christensen, G; Finsnes, F; Lyberg, T; Skjønsberg, OH | 1 |
3 other study(ies) available for bosentan anhydrous and Eosinophilia, Tropical
Article | Year |
---|---|
Bosentan-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
Topics: Aged; Anti-Ulcer Agents; Bosentan; Drug Hypersensitivity; Eosinophilia; Exanthema; Female; Fever; Humans; Scleroderma, Systemic; Sulfonamides; Syndrome | 2010 |
Drug eruption due to bosentan in a patient with systemic sclerosis.
Topics: Anti-Inflammatory Agents; Antihypertensive Agents; Bosentan; Drug Eruptions; Endothelin Receptor Antagonists; Eosinophilia; Female; Humans; Hypertension, Pulmonary; Middle Aged; Prednisolone; Scleroderma, Systemic; Sulfonamides | 2006 |
Effect of endothelin antagonism on the production of cytokines in eosinophilic airway inflammation.
Topics: Animals; Bosentan; Bronchitis; Bronchoalveolar Lavage Fluid; Cytokines; Endothelins; Eosinophilia; Inflammation Mediators; Lung; Male; Osmolar Concentration; Rats; Rats, Wistar; RNA, Messenger; Sulfonamides | 2001 |